Access to Breast Cancer Diagnosis Act of 2023

Bill 118 hr 3851, also known as the Access to Breast Cancer Diagnosis Act of 2023, aims to improve access to breast cancer diagnosis for women across the United States. The bill focuses on increasing funding for breast cancer screening programs, particularly for low-income and underserved communities.

One of the key provisions of the bill is the expansion of Medicaid coverage for breast cancer screenings, including mammograms and other diagnostic tests. This will ensure that more women have access to these life-saving screenings, regardless of their financial situation.

Additionally, the bill includes funding for research into new and improved breast cancer diagnostic technologies, with the goal of making early detection more accurate and accessible. This research will also focus on disparities in breast cancer diagnosis and treatment among different populations, with the aim of reducing these disparities and improving outcomes for all women. Overall, the Access to Breast Cancer Diagnosis Act of 2023 is a comprehensive piece of legislation that seeks to improve access to breast cancer diagnosis for all women in the United States. By increasing funding for screenings, research, and technology, the bill aims to save lives and reduce the burden of breast cancer on individuals, families, and communities.